Study of the Safety and Effectiveness of LGH447 and BYL719 in Patients With Relapsed and Refractory Multiple Myeloma
Clinical trial NCT02144038 · COMPLETED
Trial details
- NCT number
- NCT02144038
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-23
- Primary completion
- 2015-10-28
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.